Prevention of stroke: antiplatelet therapy.
Sethi, P.K. (2002) Prevention of stroke: antiplatelet therapy. Neurosciences Today, 6 (4). pp. 245-248.
Full text available as:
Antiplatelet therapy is mainstay of secondary stroke prevention. It is recommended that every patient who has experienced a non cardioembolic stroke or TIA should receive an antiplatelet agent regularly to reduce the risk of recurrent stroke and other vascular events. Aspirin, or combination of aspirin with dipyridamole or clopidogrel are acceptable option or initial therapy. Fos patients who are allergic to aspirin, clopridogrel in favour of ticlopidine is recommended.
Archive Staff Only: edit this record